Website
Mesoblast LimitedTelephone
61.3.9639.6036
Address
Level 38 55 Collins Street Melbourne, Victoria (VIC) 3000
Description
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.25 - 3.37
Trade Value (12mth)
US$1,487,900.00
1 week
4.91%
1 month
14.88%
YTD
-17.01%
1 year
826.67%
All time high
9.42
EPS 3 yr Growth
-42.50%
EBITDA Margin
-917.70%
Operating Cashflow
-$56m
Free Cash Flow Return
-9.50%
ROIC
-15.00%
Interest Coverage
-2.40
Quick Ratio
1.20
Shares on Issue (Fully Dilluted)
1088m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
USD
Short Sell (% of issue)
3.04
Date | Announcements |
---|---|
21 January 25 |
Appendix 3Y for Eric Rose
×
Appendix 3Y for Eric Rose |
20 January 25 |
Cleansing Notice
×
Cleansing Notice |
17 January 25 |
Application for quotation of securities - MSB
×
Application for quotation of securities - MSB |
16 January 25 |
Notification regarding unquoted securities - MSB
×
Notification regarding unquoted securities - MSB |
16 January 25 |
App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause
×
App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause |
16 January 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
15 January 25 |
Application for quotation of securities - MSB
×
Application for quotation of securities - MSB |
15 January 25 |
Notification regarding unquoted securities - MSB
×
Notification regarding unquoted securities - MSB |
15 January 25 |
Notification regarding unquoted securities - MSB
×
Notification regarding unquoted securities - MSB |
15 January 25 |
Notification regarding unquoted securities - MSB
×
Notification regarding unquoted securities - MSB |
15 January 25 |
Notification of cessation of securities - MSB
×
Notification of cessation of securities - MSB |
14 January 25 |
MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH
×
MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH |
14 January 25 |
Proposed issue of securities - MSB
×
Proposed issue of securities - MSB |
10 January 25 |
Change in substantial holding
×
Change in substantial holding |
10 January 25 |
Pause in Trading
×
Pause in Trading |
10 January 25 |
Trading Halt
×
Trading Halt |
10 January 25 |
Application for quotation of securities - MSB
×
Application for quotation of securities - MSB |
10 January 25 |
Application for quotation of securities - MSB
×
Application for quotation of securities - MSB |
09 January 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
06 January 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
06 January 25 |
Proposed issue of securities - MSB
×
Proposed issue of securities - MSB |
27 December 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
24 December 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
20 December 24 |
Cleansing Notice
×
Cleansing Notice |
20 December 24 |
Application for quotation of securities - MSB
×
Application for quotation of securities - MSB |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.